Why renaming this common hormonal disorder is a huge deal
Summary
Dr. Helena Teed discusses the official renaming of PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect its hormonal and metabolic nature. The episode highlights how the outdated name hindered research and led to widespread misdiagnosis and inadequate care for patients. Teed explains that this change aims to broaden treatment options beyond fertility, addressing mental health, skin issues, and insulin resistance. The shift resulted from a decade-long effort involving global experts and patient advocacy to improve understanding and outcomes.
Topics discussed
Introduction: Renaming PCOS to PMOS
Sponsors: NetSuite and Edward Jones
Patient symptoms and treatment confusion
Treatment options and fertility outcomes
The decade-long push for a name change
Patient experiences and systemic neglect
Global implementation and future optimism
Outro and sponsor messages
Listen ad-free on Castria